zoledronic acid has been researched along with Plasma Cell Tumor in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, X; Jiang, L; Ma, H; Tang, X | 1 |
| Koy, J; Koy, S; Lauer, G; Ney, M; Sabatowski, R; Schubert, M | 1 |
| Avcu, F; Ide, T; Kurt, B; Ozcan, A; Ural, AU; Yalcin, A; Yilmaz, MI | 1 |
| Eufinger, H; Hoefert, S | 1 |
2 review(s) available for zoledronic acid and Plasma Cell Tumor
| Article | Year |
|---|---|
Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trials.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Humans; Multiple Myeloma; Plasmacytoma; Randomized Controlled Trials as Topic; Treatment Outcome; Zoledronic Acid | 2021 |
[Bisphosphonate-associated osteonecrosis of the jaw].
Topics: Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Combined Modality Therapy; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Interdisciplinary Communication; Intersectoral Collaboration; Male; Middle Aged; Neoplasms; Osteoporosis; Plasmacytoma; Risk Factors; Tooth Extraction; Treatment Outcome; Zoledronic Acid | 2015 |
2 other study(ies) available for zoledronic acid and Plasma Cell Tumor
| Article | Year |
|---|---|
The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristane.
Topics: Animals; Carcinogens; Diphosphonates; Disease-Free Survival; Female; Imidazoles; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Plasmacytoma; Terpenes; Treatment Outcome; Zoledronic Acid | 2005 |
[Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].
Topics: Aged; Alendronate; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Mouth Diseases; Osteonecrosis; Osteoporosis, Postmenopausal; Pamidronate; Plasmacytoma; Radiography, Panoramic; Risk Factors; Zoledronic Acid | 2005 |